Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neven

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|March 9, 2010
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatmentE Despierre, D Lambrechts, P Neven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancerI Vandenput, F Amant, P Neven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1994
Multivariate analysis of factors affecting survival in pelvic exenterationJ.H. Shepherd, H.Y.S. Ngan, P. Neven, et al.
Gynecologic Oncology|June 1, 1993
Reconstruction of the abdominal wall with a latissimus dorsi musculocutaneous flap: a case of a massive abdominal wall metastasis from a cervical cancer requiring palliative resectionP Neven, J H Shepherd, K F Tham, et al.
Clinical Breast Cancer|November 14, 2022
Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-MethodM Van Houdt, S N Han, S Pauwels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 2012
A critical review why assessment of steroid hormone receptors in breast cancer should be quantitativeO Brouckaert, R Paridaens, G Floris, et al.
Gynecologic Oncology|December 4, 2009
Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancerD Tsolakidis, F Amant, T Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2008
Timing of debulking surgery in advanced ovarian cancerI Vergote, T van Gorp, F Amant, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrantI Vergote, F Amant, K Leunen, et al.
Minerva Ginecologica|September 29, 2006
The position of neoadjuvant chemotherapy within the treatment of ovarian cancerT Van Gorp, F Amant, P Neven, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|March 9, 2010
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatmentE Despierre, D Lambrechts, P Neven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2007
Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancerI Vandenput, F Amant, P Neven, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1994
Multivariate analysis of factors affecting survival in pelvic exenterationJ.H. Shepherd, H.Y.S. Ngan, P. Neven, et al.
Gynecologic Oncology|June 1, 1993
Reconstruction of the abdominal wall with a latissimus dorsi musculocutaneous flap: a case of a massive abdominal wall metastasis from a cervical cancer requiring palliative resectionP Neven, J H Shepherd, K F Tham, et al.
Clinical Breast Cancer|November 14, 2022
Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-MethodM Van Houdt, S N Han, S Pauwels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 2012
A critical review why assessment of steroid hormone receptors in breast cancer should be quantitativeO Brouckaert, R Paridaens, G Floris, et al.
Gynecologic Oncology|December 4, 2009
Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancerD Tsolakidis, F Amant, T Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2008
Timing of debulking surgery in advanced ovarian cancerI Vergote, T van Gorp, F Amant, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrantI Vergote, F Amant, K Leunen, et al.
Minerva Ginecologica|September 29, 2006
The position of neoadjuvant chemotherapy within the treatment of ovarian cancerT Van Gorp, F Amant, P Neven, et al.
Pageof 14